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On the basis of clinical observations, a  widespread opinion prevails 
that  immunity to influenza is of brief duration.  This  has  usually 
been explained as due to one of two circumstances:  (1) An attack of 
influenza is not followed by the formation of specific antibodies in the 
serum of the patient, or, if so, they persist for only a short time.  (2) 
Many strains of the infectious agent are commonly in circulation, and 
the human individual may be attacked repeatedly by strains of dif- 
ferent serological specificity.  The lack of knowledge of the nature of 
the causative agent, and the failure to transmit the disease consistently 
to laboratory animals, have made it impossible heretofore to submit 
the various hypotheses to experimental tests. 
Recent studies (1-3), however, appear to have established the fact 
that the primary causative agent of human influenza is a  filterable 
virus.  In  this  laboratory  the  virus  has  been  recovered from  the 
nasopharynx of patients suffering from influenza in Puerto Rico and 
Philadelphia.  These  strains,  (designated  P.R.8  and  Phila.)  have 
been repeatedly transferred both in ferrets and mice.  In both species 
of animals an experimental disease characterized by involvement of 
the respiratory  tract,  especially of  the  lungs,  has  been  produced. 
Serum of ferrets recovered from infection with either of these strains of 
virus was found to neutralize the infectivity of both strains for mice. 
Furthermore, the serum of a horse immunized by Andrewes, Laidlaw 
and Smith (2) against a strain of virus (W.S.) recovered in England, 
was also found to neutralize  both  the  P.R.8  and  Phila. strains  of 
virus.  The serum of swine and ferrets which neutralized the virus 
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of swine influenza  (Shope  (4))  failed, however, to neutralize  the  re- 
cently isolated human  strains of virus.  These results  (5)  show that 
the strains of virus recovered from human  cases of influenza are im- 
munologically identical, while the virus of swine influenza differs from 
them  serologically.  Nevertheless,  certain  evidence  to  be  presented 
in  the  present  paper  indicates  that  an  immunological  relationship 
exists between the strains of human and swine influenza virus.  Simi- 
lar observations have been reported by the English investigators  (6) 
who  have,  in  addition,  recovered several  immunologicaUy identical 
strains of human virus from different outbreaks  of  influenza  in  En- 
gland. 
The present  report deals with  additional studies  of the immunity 
reactions of animals  to  the  P.R.8  and  Phila.  strains  of  virus,  and 
with  certain  results  obtained  with  human  sera  which  indicate  the 
etiological relationship of the virus to the human  disease. 
Materials and Methods 
Strains of Virus.--The strains of virus used in the present study were obtained 
from sputum  or  pharyngeal washings  of patients  suffering  from  influenza  in 
Puerto Rico (P.R.8)  and Philadelphia.  In ferrets the disease produced by the 
P.R.8 strain is somewhat more severe than that produced by the Phila. strain. 
The pulmonary lesions in ferrets infected with the P.R.8 strain are usually more 
extensive, and the respiratory symptoms are more marked.  The characteristics 
of the experimental disease produced by these two strains in mice are identical. 
Mice.--Albino  mice of the Swiss strain were used throughout.  Young mice 
4--6 weeks of age are most satisfactory.  In older mice irregular survivals are more 
frequent, and death of the infected animals  is somewhat delayed. 
Neutralization  Tests.--The  technique  of  the  virus  neutralization  tests  has 
previously been described (5).  The serum to be tested is mixed with a  10 per 
cent suspension  of infected mouse lung in saline,  and, after incubation, 0.03 cc. 
of the mixture is inoculated into the nasal passages  of 4 or 5 anesthetized mice. 
If the mice die, their lungs are removed and the extent of the pulmonary con- 
solidation is noted.  All surviving mice are killed on the 6th day after infection, 
and the extent of pulmonary involvement recorded.  The absence of pulmonary 
lesions in mice receiving  virus and serum is taken to indicate the fact that the 
serum possesses specific neutralizing antibodies. 
Isolation.--When  ferrets are received from the breeders they are  placed in 
quarantine for a period of 2-4 weeks and observed for any signs of illness.  During 
the winter certain of the animals were found to carry hemolytic streptococci or 
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purulent  rhinitis sometimes occurred.  Such  animals were segregated from other 
stock. 
Mter this period of observation, the ferrets are transferred to another quaran- 
tine room, from which they are transported  to the isolation units when needed for 
experimental purposes.  At no time are they exposed to experimentally infected 
animals or to persons who have contact with infected animals. 
Active Immunity in Ferrets 
In a previous publication (5) it was shown that the serum of ferrets 
which have recovered from infection with  either  the  P.R.8  or Phila. 
strain of influenza virus is capable of passively protecting white mice 
against both strains  of virus. 
In  addition  to  possessing  neutralizing  antibodies  in  their  blood, 
ferrets recovering from infection with one strain  have been found to 
be actively immune  to reinfection with either the homologous or het- 
erologous strain.  The duration of this active immunity  is somewhat 
variable.  In most instances,  tests made 4 months after previous in- 
fection  have  shown  the  animals  to  be  resistant  to  reinfection.  In 
certain  instances,  however,  reinoculation  has  been  followed  by  a 
single sharp  rise of temperature  in the first 24 hours, without subse- 
quent  evidence of infection.  Reactions of this  type have been con- 
sidered to be either  non-specific or of the nature  of accelerated im- 
mune  reactions. 
These results appear  to indicate  clearly that  the active immunity 
which follows infection with one strain is fully effective against rein- 
fection with  the  other  strain.  The  fact  that  a  comparatively  firm 
active immunity may persist for months in previously infected ferrets 
is in complete agreement with the observations of the British workers 
(1, 6).  Infrequently, however, reinfection has occurred in animals re- 
ceiving a  second intranasal  inoculation within  a  period of 2 months. 
In these cases the only evidence of reinfection was the persistence of 
fever for 2-3 days after the second inoculation. 
It was of interest,  therefore,  to note that one shipment of animals 
from a  known susceptible stock was found to be resistant  to experi- 
mental  infection.  Another  group  of animals  from  the  same  source 
was  completely  susceptible.  A  third  group,  obtained  from  this 
breeder, on arrival at the laboratory exhibited nasal discharge.  Cer- 
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mental  purposes  and  inoculated  intranasally  with  active  influenza 
virus, developed no febrile or constitutional reaction, and attempts to 
recover  virus  from  the  nasal  mucous  membranes  or  lungs  of such 
animals were unsuccessful.  In other instances a moderate fever with- 
out other symptoms persisted for 3-4 days after inoculation,  but the 
inoculation  of  suspensions  of  the  lungs  and  turbinates  of  these  ani- 
mals into normal susceptible ferrets failed to produce the experimental 
disease.  It  was  assumed,  therefore,  that  these  ferrets  had  become 
immune,  although  they  had  not  been  subjected  to  experimental 
infection. 
To test this assumption, serum was obtained from 5 ferrets of the third group 
and of several other ferrets which had been kept in the same room for a period of 
months.  The serum of 2 of the 5 ferrets of this group was found to contain anti- 
bodies which neutralized the P.R.8 virus in mouse tests. 
6 months after they had been received from the dealer, the  2 ferrets whose 
serum contained neutralizing antibodies, together with a third animal of the same 
group which  did not possess neutralizing antibodies, were inoculated simultane- 
ously with  the  Phila.  virus.  The control animal developed fever in  24 hours, 
lost its appetite and exhibited catarrhal rhinitis  and mild respiratory distress. 
When sacrificed on the 4th day after the onset of fever, involvement of practically 
all of both lower lobes of the lung was found.  The 2 ferrets, presumably immune, 
developed fever on the 2rid day after inoculation, but remained well thereafter. 
When sacrificed  on the 4th day after the development of fever, the lungs of both 
animals were normal in appearance.  The turbinates were somewhat mucoid. 
From one of these latter animals a  20 per cent suspension of ground lung and 
turbinate tissue was made and inoculated intranasally into a normal ferret.  Like- 
wise, the lung and turbinates of the control animal were ground to form a 10 per 
cent suspension and administered to another normal ferret.  The animal which 
received the latter material became sick, and when sacrificed on the 4th day pul- 
monary consolidation was found.  The ferret which received the passage material 
from the animal possessing  neutralizing antibodies had a mild febrile reaction on 
the 2nd day, but appeared perfectly well.  When sacrificed  on the 4th day, no 
pulmonary involvement was observed,  although  the  nasal mucous membranes 
were swollen  and contained some mucopurulent material from which  hemolytic 
streptococci were recovered. 
The fact that the two ferrets which possessed circulating neutraLiz- 
ing  antibodies  exhibited  only  a  brief  febrile  reaction  and  failed  to 
develop lung lesions, in contrast to the normal control animal of the 
same group,  is of interest.  Furthermore,  passage from one  of these 
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normal ferret, whereas the animal which received material from the 
control ferret developed distinct pulmonary lesions.  This indicates 
that following the experimental infection of the ferrets whose serum 
contained neutralizing  antibodies  the  virus  was  either  completely 
neutralized or persisted in only small amounts, since heavy suspen- 
sions of the tissues of these animals failed to induce a typical infection 
when injected into a  normal ferret. 
The fact that immune ferrets may be  encountered among stock 
animals not infected experimentally  must be taken into account in all 
studies relating to immunity.  Whether the neutralizing antibodies 
present in the serum of these animals develop solely in response to 
contact infection of human origin, is a problem the solution of which 
must await further study.  In view of these observations, it is  ex- 
tremely important that strict isolation be carried out in the care of 
animals used for experimental purposes. 
Immunization of Rabbits 
During the course of experiments with Rift Valley fever virus, it 
was found that rabbits which were inoculated intraperitoneally with 
the virus presented no evidence of infection.  These animals, how- 
ever,  subsequently developed in  the  circulating blood  neutralizing 
antibodies for the virus of Rift Valley fever (7). 
It seemed important, therefore, to determine whether rabbits inocu- 
lated intraperi{oneally with the influenza virus subsequently developed 
demonstrable neutralizing antibodies in their serum. 
Two adult male Chinchilla rabbits were used.  Serum was obtained 
for  control purposes  before inoculation.  Both  animals  were  then 
given, intraperitoneally, 5.0 cc. of a 10 per cent emulsion of lung and 
turbinates  of  a  ferret  infected with  the  P.R.8  strain of influenza 
virus.  No  fever or other evidence of infection occurred.  28  days 
later a similar inoculation was made by the same route.  The serum 
obtained  14  days after the  second injection was found to  contain 
antibodies  which  neutralized both  the  P.R.8  and Phila.  strains of 
virus  in  mice,  while  the  serum before inoculation was  ineffective. 
This immune serum was tested by Shope against the virus of swine 
influenza and found to neutralize that virus in mouse tests.  Similar 
results  have  been  obtained  in  rabbits"  inoculated  with  the  Phila. ,510  VIRUS  01~  INFLUENZA 
strain of virus.  This evidence, like that obtained in the case of Rift 
Valley fever, indicates that rabbits, although apparently insusceptible 
to infection, are nevertheless capable of giving rise to the formation of 
specific antibodies in response to the antigenic action of the virus. 
Immunization of Mice 
The  virulence  of  influenza  virus  for mice  has  been  progressively 
enhanced by repeated passage through these animals.  The virulence 
of the  strains  used  in  the present  studies  is  such  that  0.03  cc.  of a 
1:1000  dilution  of infected mouse lung  inoculated intranasally  pro- 
duces a  fatal infection, and a  similar  amount of a  1:10,000  dilution 
produces  pulmonary lesions from which  the mice may  recover.  In 
contrast to the virulence by the intranasal route, it has been repeatedly 
observed  that  as  much  as  0.2  cc.  of a  10  per  cent  suspension  sub- 
cutaneously, or 0.5  cc. intraperitoneally, produces no evidence of in- 
fection.  Similarly,  suspensions  of infected ferret lung  or  Berkefeld 
filtrates of lungs and turbinates which contain active virus, as shown 
by  intranasal  infection,  produce  no  evidence  of  infection  in  mice 
when injected in large amounts by the subcutaneous or the intraperi- 
toneal  route.  It  was  found,  however,  that  animals  so  treated  be- 
come actively resistant  to intranasal  infection with  the virus. 
Immunization of Mice with Influenza Virus (Strain P.R.g).--Each  of 20 normal 
young mice was given,  subcutaneously, 0.2 cc. of a  10 per cent broth emulsion 
of the lungs  of mice infected with P.R.8 strain of human influenza  virus.  As 
controls, 20 normal mice were each given 0.2 co. of a  10 per cent suspension  of 
normal mouse lung by the same  route.  Mter 14 days the virus-vaccinated mice 
each received,  intraperitoneaUy, 0.2 co. of a  l0 per cent suspension  of the lungs 
of mice infected with P.R.8 virus.  At the same time, the control mice each re- 
ceived the same amount, intraperitoneally, of a 10 per cent suspension of normal 
mouse lung.  1 week  after the second injection, all mice,  slightly anesthetized 
with ether, were inoculated intranasally with 0.05 co. of a 10 per cent suspension 
of P.R.8 mouse virus.  By the 6th day after inoculation all but one of the control 
mice vaccinated with normal mouse lung were dead, and at autopsy all exhibited 
consolidation  of both lungs.  The virus-vaccinated mice were all well and pre- 
sented no evidence of infection.  6 of these mice were sacrificed and their lungs 
examined.  No pulmonary lesions were detected.  The remaining 14 mice which 
had been found actively immune to intranasal infection with the strain of virus 
used for vaccination were then retested to determine their resistance to a strain 
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nasally with 0.05 cc. of a 10 per cent suspension  of the Phila. strain of virus.  All 
the vaccinated mice were found to be immune to the second strain of virus. 
Similar results have been obtained in mice vaccinated against the 
Phila. strain of virus and subsequently retested with the P.R.8 strain 
of mouse virus.  Furthermore, the serum of mice so treated has been 
found to contain antibodies which neutralize the infectivity of both 
strains of virus.  In a similar manner mice have been vaccinated with 
virus-containlng material  derived  from  infected ferrets.  Both  un- 
filtered suspensions of virus material and Berkefeld filtrates of these 
suspensions have been used.  The resultant active immunity appears 
to be quite as effective as that obtained in mice vaccinated with mouse 
passage virus.  The living virus, therefore, functions as an immuniz- 
ing agent irrespective of the species of animal from which the in- 
fectious material is derived.  Smith, Andrewes and Laidlaw (8), in a 
recent article, have described their results regarding the immuniza- 
tion of mice by the subcutaneous inoculation of mouse virus. 
Different intervals  between the vaccinating injections have  been 
tried,  and  the interval  between the  last  vaccinating dose  and  the 
intranasal infection has been varied.  The best results have been ob- 
tained,  so  far,  by  giving 3  consecutive subcutaneous injections at 
7-10  day intervals,  or with a  single subcutaneous dose  followed 2 
weeks later by an intraperitoneal injection.  Single subcutaneous or 
intraperitoneal doses of living virus have not, up to the present, re- 
sulted  in  effective immunity.  Nevertheless,  mice  recovering from 
the experimental disease induced by intranasal infection have been 
found actively resistant to reinfection. 
Certain groups of these immunized mice have been tested by Shope 
and found to be actively resistant to infection with swine influenza 
virus as well.  The significance of these results will be considered in 
a  later publication. 
Neutralization  Tests with Serum of Patients Suffering from Respiratory 
Infections 
Serum was obtained from 3 patients admitted to  the Hospital of 
The  Rockefeller Institute suffering from  influenza.  The  serum  of 
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disease was tested for the presence of neutralizing antibodies against 
both the  P.R.8  and  Phila. strains of influenza virus.  In comparison 
with normal ferret or normal horse serum, most human sera have an 
inhibitory  effect upon  the  activity  of  the  virus.  Nevertheless,  the 
serum of these individuals taken during the acute  stage of influenza 
failed to prevent the development of pulmonary lesions in mice inocu- 
lated  with  serum-virus  mixtures,  while  the  convalescent  sera  uni- 
formiy protected the animals.  Furthermore, the antibodies develop- 
TABLE I 
Neutralization  Tests in Mice with Serum of Influenza  Patients 
H.F. 
B.P. 
M.B. 
Serum 
Acute  .............................. 
Convalescent  ....................... 
6 mos. later  ......................... 
Acute  .............................. 
Convalescent  ........................ 
6 mos. later ......................... 
Acute  .............................. 
Convalescent ....................... 
6  mos. later ......................... 
Influenza  virus (P.R.8 strain) 
Severity of pulmonary  lesions  in mice 
No. 4  1  N°'____!__ 
+il+i 
0  0 
0  0 
?  + 
0 
0  0 
No. 3 
0 
+++ 
0 
0 
++ 
0 
0 
+++ 
0 
0 
++ 
.4- 
+++ 
0 
0 
0  ffi no pulmonary lesion. 
4- to -I- ~- ~- Jr ~-  ffi progressive degrees of pulmonary involvement. 
ing in  early  convalescence were found to  persist  for 6-8  months  at 
least. 
Similar tests were made with the serum of patients acutely ill with, 
and  convalescent from, pneumococcus pneumonia.  In  general,  the 
effect of convalescent pneumonia serum upon the influenza virus ap- 
peared to be no different from that of the serum taken at the height 
of the illness.  Neutralizing antibodies for the influenza virus did not 
develop in  response to the pneumococcus infection.  If neutralizing 
antibodies were present at the onset of the iUness, they were likewise 
present  in  the  convalescent  serum.  In  the  one  instance  in  which THOMAS  ]?RANCIS,  JR.~  AND  T.  P.  MAGILL  513 
neutralizing antibodies did develop in convalescence from pneumonia, 
it  seemed quite  likely from the clinical history that  influenza may 
have been associated with the onset of the pneumonia. 
TABLE  II 
Neutralization  Tests in Mice with Serum of Pneumonia Patients 
M.C. 
Serum 
Acute .......................... 
Convalescent  ................... 
Influenza virus (P.R.8 strain) 
Severity of pulmonary lesions in mice 
No. l  No. 2  No. 3  No. 4 
0  0  0  0 
0  0  0  0 
j.c. 
A.W. 
R.O. 
C.P. 
C.M. 
H.C. 
B.W. 
Acute ..........................  +++ 
Convalescent  ..................  •  +'4-+ 
Acute ..........................  +  + 
Convalescent  ..................  +  + 
Acute .........................  0 
Convalescent...  0 
Acute  ..........................  + 
Convalescent  ...................  ++ 
Acute  .........................  0 
Convalescent  ..................  0 
Acute .........................  +++ 
Convalescent  ..................  +++ 
Acute ..........................  + 
Convalescent  ..................  0 
++  ++  0 
++  +  0 
+  ++  0 
+  0  ++ 
+  0  ++ 
0  +++  + 
+  +  0 
0  +  0 
0  0  + 
+++  ++  +++ 
+++  ++  ++++ 
++  ++  + 
0  0  0 
Control 
influenza 
I-I.F. 
Acute .........................  -i  +++  ++  ++  +++ 
Convalescent  ..................  .I  0  0  0  0 
0  =  no pulmonary  lesions. 
+  to  +  +  +  +  ffi progressive degrees of pulmonary  involvement. 
Further studies were made with the serum of 4  individuals taken 
before, during and after the course of a common cold.  In the 4 cases 
studied,  the  effect of the individual's  serum on the influenza virus 
was entirely uninfluenced by the common cold. 514  VIRUS  O~  INFLUENZA 
These  results  indicate  that  the  development of  antibodies  which 
neutralize the influenza virus is  a  specific response to the infectious 
agent, and that the virus is causally related to the human disease-- 
influenza. 
TABLE  III 
Neutralization  Tests  in  Mice  with  Serum  of Human  Individuals  before, during  and 
after a  Common  Cold 
R.L. 
T.A. 
F.H. 
T.F. 
Serum 
Before cold  ...................... 
During  "  ...................... 
After  "  ...................... 
Before cold  ...................... 
During  "  ...................... 
After  "  ...................... 
Before cold  ...................... 
During  "  ...................... 
After  "  ...................... 
Influenza virus (P.R.8 strain) 
Severity of pulmonary lesions in mice 
No. 1  No. 2  No. 3  No. 4 
++ 
+ 
++ 
+ 
+ 
4- 
0" 
0 
0 
Before cold  ......................  [-+q--l- + 
During  "  . .....................  +++++ 
After  "  ......................  q- q- 
+ 
+ 
+ 
+ 
++ 
++ 
-4- 
o 
+ 
+++ 
+++++ 
++++ 
++ 
++ 
++ 
++ 
+ 
-4- 
+++ 
+ +++++  + 
++ 
+ 
+ 
++ 
+ 
+ 
+ 
++++ 
++ 
0  ffi  no pulmonary  lesions. 
4-  to  +  +  +  +  +  =  progressive  degree of pulmonary  involvement. 
DISCUSSION 
The evidence presented in this report demonstrates that a  state of 
immunity as measured by circulating antibodies and active resistance 
follows recovery from infection with the virus of influenza.  That the 
mere presence of neutralizing antibodies in the circulating blood may 
not  necessarily  assure  a  complete  refractory state  to  reinfection is 
recognized.  Ferrets  which  have  developed  neutralizing  antibodies 
following experimental or presumably direct infection exhibit little or 
no reaction to reinfection.  In certain instances, however, relnocula- 
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fection.  Attempts to recover virus from these animals have in general 
been unsuccessful.  The results in experimental animals indicate that 
although the immunity acquired as a  result of infection may not be 
sufliciently absoIute to prevent febrile reactions on reinfection, the 
virus is quickly neutralized and from these animals is not so readily 
recoverable as it is from normal animals infected for the first time. 
If a similar set of drcumstances prevails in the natural disease in man, 
the experimental results suggest a possible explanation for the lack of 
uniform success in attempts to recover virus from all patients with 
influenza. 
Virus neutralization tests with serum of influenza patients taken 
during the acute stage of the disease, during early convalescence and 
at later periods, have shown that the serum of the individual at the 
height of the disease fails to neutralize the influenza virus, whereas 
serum taken from the same patient during convalescence does contain 
specific antibodies.  These antibodies are not evanescent, but persist 
for several months at least, as evidenced by the neutralizing capacity 
of  serum  obtained  from patients  6-8  months after  recovery  from 
influenza. 
Similar studies with the serum of patients ill with, and recovering 
from, pneumococcus pneumonia, have shown that in general specific 
antibodies neutralizing the influenza virus do not develop in response 
to pneumococcus infection.  Studies of the antibody content of the 
serum of human individuals before, during and after a  common cold 
were made.  The results indicate that this type of respiratory infec- 
tion does not stimulate the formation of antibodies against the virus 
of influenza.  It appears,  therefore, that  the neutralizing action of 
the serum of human individuals is a specific response to infection with 
the influenza virus. 
That the virus of swine influenza is not serologically identical with 
the strains of virus recently isolated from human cases of influenza 
seems definitely established  (5).  Nevertheless,  that  the  strains  of 
human influenza virus and of swine influenza virus are related is shown 
by the active cross-immunity in ferrets (6), and in mice immunized 
with the P. R. 8 or Phila. virus, as well as by passive neutralization of 
swine influenza virus by the serum of rabbits immunized with P. R. 8 
virus.  Further consideration of this problem will form the basis of a 516  VIRUS OF  INFLUENZA 
subsequent report.  It has been suggested, moreover, that the virus of 
swine influenza is the etiological agent which gave rise to the 1918 pan- 
demic of influenza in man (6).  If this is subsequently shown to be 
true, the problem of immunity to influenza will of necessity involve 
consideration of the possible existence of multiple strains of virus of 
related but not wholly identical antigenic structure. 
SUMMARY 
Following infection with  the virus of influenza, both  ferrets  and 
mice develop a  state of active immunity to reinfection.  The serum 
of these animals contains neutralizing antibodies, as evidenced by the 
capacity of the serum to confer passive protection to mice against in- 
fection with the P.R.8  and  Phila.  strains  of  the  virus  of  human 
influenza. 
Rabbits  which are apparently insusceptible to infection with the 
virus of influenza produce specific antibodies in response to repehted 
injection of virus-containing material.  The serum of immunized rab- 
bits affords passive protection to mice against mouse-virulent virus. 
Although the subcutaneous or intraperitoneal injection of the living 
virus does not produce infection in mice, animals so treated acquire 
active immunity against subsequent infection by the intranasal route. 
Neutralization tests  with  the serum of patients  before and  after 
recovery from influenza, pneumonia and the common cold indicate 
that neutralizing antibodies arise as a  specific response to infection 
with the virus of influenza. 
The immunological identity of strains of influenza virus recovered 
from human sources has been established, and the possible existence 
of strains of related, but not identical, antigenic structure is discussed. 
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